These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31851022)

  • 1. Look at the cognitive deficits in patients with myotonic dystrophy type 1: an exploratory research on the effects of virtual reality.
    Maresca G; Portaro S; Naro A; Scarcella I; Bramanti P; Militi D; Accorinti M; De Luca R; Calabrò RS
    Int J Rehabil Res; 2020 Mar; 43(1):90-94. PubMed ID: 31851022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive recovery in people with relapsing/remitting multiple sclerosis: A randomized clinical trial on virtual reality-based neurorehabilitation.
    Leonardi S; Maggio MG; Russo M; Bramanti A; Arcadi FA; Naro A; Calabrò RS; De Luca R
    Clin Neurol Neurosurg; 2021 Sep; 208():106828. PubMed ID: 34332269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocephalus and cognitive decline in myotonic dystrophy: case report and literature review.
    Moroz A; Kalva S
    Arch Phys Med Rehabil; 1998 Aug; 79(8):1022-3. PubMed ID: 9710180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in neuroRehabilitation of TREM2-related dementia: A case report on a novel multimodal approach using virtual reality.
    De Luca R; Marra A; Pollicino P; Buda M; Mucari M; Bonanno M; Torregrossa W; Caminiti A; Rifici C; Calabrò RS
    Medicine (Baltimore); 2022 May; 101(21):e29470. PubMed ID: 35623081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Growing Use of Virtual Reality in Cognitive Rehabilitation: Fact, Fake or Vision? A Scoping Review.
    Maggio MG; Maresca G; De Luca R; Stagnitti MC; Porcari B; Ferrera MC; Galletti F; Casella C; Manuli A; Calabrò RS
    J Natl Med Assoc; 2019 Aug; 111(4):457-463. PubMed ID: 30739728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Virtual Reality Cognitive Rehabilitation Improve Executive Functioning and Coping Strategies in Traumatic Brain Injury? A Pilot Study.
    De Luca R; Bonanno M; Marra A; Rifici C; Pollicino P; Caminiti A; Castorina MV; Santamato A; Quartarone A; Calabrò RS
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive training on stroke patients via virtual reality-based serious games.
    Gamito P; Oliveira J; Coelho C; Morais D; Lopes P; Pacheco J; Brito R; Soares F; Santos N; Barata AF
    Disabil Rehabil; 2017 Feb; 39(4):385-388. PubMed ID: 25739412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of robotic neurorehabilitation through lokomat plus virtual reality on cognitive function in patients with traumatic brain injury: A retrospective case-control study.
    Maggio MG; Torrisi M; Buda A; De Luca R; Piazzitta D; Cannavò A; Leo A; Milardi D; Manuli A; Calabro RS
    Int J Neurosci; 2020 Feb; 130(2):117-123. PubMed ID: 31590592
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving motor performance in Parkinson's disease: a preliminary study on the promising use of the computer assisted virtual reality environment (CAREN).
    Calabrò RS; Naro A; Cimino V; Buda A; Paladina G; Di Lorenzo G; Manuli A; Milardi D; Bramanti P; Bramanti A
    Neurol Sci; 2020 Apr; 41(4):933-941. PubMed ID: 31858331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
    Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
    Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving post-stroke cognitive and behavioral abnormalities by using virtual reality: A case report on a novel use of nirvana.
    De Luca R; Torrisi M; Piccolo A; Bonfiglio G; Tomasello P; Naro A; Calabrò RS
    Appl Neuropsychol Adult; 2018; 25(6):581-585. PubMed ID: 29020466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive training in an everyday-like virtual reality enhances visual-spatial memory capacities in stroke survivors with visual field defects.
    Dehn LB; Piefke M; Toepper M; Kohsik A; Rogalewski A; Dyck E; Botsch M; Schäbitz WR
    Top Stroke Rehabil; 2020 Sep; 27(6):442-452. PubMed ID: 31960760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.
    Antonini G; Soscia F; Giubilei F; De Carolis A; Gragnani F; Morino S; Ruberto A; Tatarelli R
    J Rehabil Med; 2006 May; 38(3):181-5. PubMed ID: 16702085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual Reality and Cognitive Rehabilitation in People With Stroke: An Overview.
    Maggio MG; Latella D; Maresca G; Sciarrone F; Manuli A; Naro A; De Luca R; Calabrò RS
    J Neurosci Nurs; 2019 Apr; 51(2):101-105. PubMed ID: 30649091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized cognitive training using virtual reality on everyday life activities for patients recovering from stroke.
    Oliveira J; Gamito P; Lopes B; Silva AR; Galhordas J; Pereira E; Ramos E; Silva AP; Jorge Á; Fantasia A
    Disabil Rehabil Assist Technol; 2022 Apr; 17(3):298-303. PubMed ID: 32255695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
    Gaul C; Schmidt T; Windisch G; Wieser T; Müller T; Vielhaber S; Zierz S; Leplow B
    Neurology; 2006 Jul; 67(2):350-2. PubMed ID: 16864839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual reality in cognitive and motor rehabilitation: facts, fiction and fallacies.
    Tieri G; Morone G; Paolucci S; Iosa M
    Expert Rev Med Devices; 2018 Feb; 15(2):107-117. PubMed ID: 29313388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive assessment in patients with myotonic dystrophy type 2.
    Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
    Theodosiou T; Christidi F; Xirou S; Bede P; Karavasilis E; Papadopoulos C; Kourtesis P; Pantoleon V; Kararizou E; Papadimas G; Zalonis I
    Cogn Behav Neurol; 2021 Mar; 34(1):1-10. PubMed ID: 33652465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.